According to a recent LinkedIn post from Resilience Care, the company plans to participate again in the SantExpo healthcare trade fair in Paris in May 2026, focusing discussions on telemonitoring. The post emphasizes sector-wide challenges in France, including fragmented care pathways, organizational strain in hospitals, and underused health data for clinical decision-making.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post highlights telemonitoring as a lever to improve continuity of care, optimize medical time and hospital coordination, and enhance interoperability and the use of health data for care and research. It notes that Resilience Care’s telemonitoring solutions in oncology, psychiatry, and gastroenterology are already deployed in more than 200 healthcare facilities, suggesting a growing installed base and reference network.
From an investor perspective, recurring participation in SantExpo may support business development by increasing visibility with hospital decision-makers and clinical partners in the French and potentially broader European markets. The reported scale of deployment, if sustained or expanded, could contribute to recurring revenue opportunities tied to software, services, and data-enabled offerings in telehealth and remote patient monitoring.
The emphasis on interoperability and data for research also points to potential longer-term value in data analytics, clinical evidence generation, and partnerships with pharmaceutical or research organizations. In a context of systemic pressure on healthcare systems, solutions that claim to enhance efficiency and care personalization could strengthen Resilience Care’s competitive positioning within the digital health and telemonitoring segment.